Pharma veteran Umang Vohra to lead Advent-backed Cohance Lifesciences as chairman and CEO, succeeding Vivek Sharma amid efforts to revive growth and address regulatory challenges
Cohance Lifesciences share price today: Cohance Lifesciences, a contract development and manufacturing organisation, has appointed Cipla's ex-CEO Umang Vohra as its executive chairman and group CEO.
Cohance Lifesciences rose as much as 8.5 per cent to the day's high of ₹331.20 on the National Stock Exchange (NSE) following a block deal
In the previous session, Cohance Lifesciences hit a 52-week low of ₹303.5 on the National Stock Exchange (NSE)